A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases

British Journal of Cancer

Volumn 116, Issue 12, 2017, Pages 1513-1519

  Siddiqui, Muhammed R S ^a,b   Simillis, Constantinos ^c   Hunter, Chris ^a,b   Chand, Manish ^a,b   Bhoday, Jemma ^a,b   Garant, Aurelie ^d   Vuong, Te ^d   Artho, Giovanni ^d   Rasheed, Shahnawaz ^c   Tekkis, Paris ^c   Abulafi, Al Mutaz ^a   Brown, Gina ^b  

^a MAYDAY UNIVERSITY HOSPITAL   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

extramural vascular invasion; MRI; rectal cancer

Indexed keywords

ARTICLE; CANCER PROGNOSIS; HUMAN; META ANALYSIS; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; RECTUM CANCER; RISK ASSESSMENT; TUMOR INVASION; BLOOD VESSEL; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; PATHOLOGY; RECTUM TUMOR; RISK FACTOR;

BLOOD VESSELS; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RECTAL NEOPLASMS; RISK FACTORS;

EID: 85020401080     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2017.99     Document Type: Article

References (52)

1. Battersby NJ, How P, Moran B, Stelzner S, West NP, Branagan G, Strassburg J, Quirke P, Tekkis P, Pedersen BG, Gudgeon M, Heald B, Brown G, Group, MIS (2016) Prospective validation of a low rectal cancer magnetic resonance imaging staging system and development of a local recurrence risk stratification model: The MERCURY II Study. Ann Surg 263: 751-760.
2. Betge J, Pollheimer MJ, Lindtner RA, Kornprat P, Schlemmer A, Rehak P, Vieth M, Hoefler G, Langner C (2012) Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Cancer 118: 628-638.
3. Bhangu A, Fitzgerald JE, Slesser A, Northover JM, Faiz O, Tekkis P (2013) Prognostic significance of extramural vascular invasion in T4 rectal cancer. Colorectal Dis 15: e665-e671.
4. Borenstein M, HL, Higgins J, Rothstein H (ed.) (2005) ComprehensiveMeta-analysis Version 2. Englewood, NJ, USA.
5. Brown CE, Warren S (1938) Visceral metastasis from rectal carcinoma. Surg Gynecol Obstet 66: 611-621.
6. Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT (2003) Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 90: 355-364.
7. Bugg WG, Andreou AK, Biswas D, Toms AP, Williams SM (2014) The prognostic significance of MRI-detected extramural venous invasion in rectal carcinoma. Clin Radiol 69: 619-623.
8. Bujko K, Glynne-Jones R, Bujko M (2010) Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radio-chemotherapy? A systematic review of randomised trials. Ann Oncol 21: 1743-1750.
9. Chalmers TC, Smith Jr H, Blackburn B, Silverman B, Schroeder B, Reitman D, Ambroz A (1981) A method for assessing the quality of a randomized control trial. Control Clin Trials 2: 31-49.
10. Chand M, Evans J, Swift RI, Tekkis PP, West NP, Stamp G, Heald RJ, Brown G (2015) The prognostic significance of postchemoradiotherapy high-resolution MRI and histopathology detected extramural venous invasion in rectal cancer. Ann Surg 261: 473-479.
11. Chand M, Swift RI, Chau I, Heald RJ, Tekkis PP, Brown G (2014a) Adjuvant therapy decisions based on magnetic resonance imaging of extramural venous invasion and other prognostic factors in colorectal cancer. Ann R Coll Surg Engl 96: 543-546.
12. Chand M, Swift RI, Tekkis PP, Chau I, Brown G (2014b) Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer. Br J Cancer 110: 19-25.
13. Courtney ED, West NJ, Kaur C, Ho J, Kalber B, Hagger R, Finlayson C, Leicester RJ (2009) Extramural vascular invasion is an adverse prognostic indicator of survival in patients with colorectal cancer. Colorectal Dis 11: 150-156.
14. Deeks JJ, Altman DG, Bradburn MJ (2001) Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Systematic Reviews in Health Care: Meta-Analysis in Context, Group, BP (ed.) 2nd edn. BMJ Publication group: London.
15. Egger M, Smith GD, Altman DG (2006) Systematic Reviews in Healthcare. BMJ Publishing: London.
16. Ernst-Stecken A, Grabenbauer G, Iro H, Plasswilm L, Sauer R (2004) Phase II trial of hyperfractionated accelerated split-course radiochemotherapy with 5-FU and Cis-DDP in advanced head and neck cancer: results and toxicity. Strahlenther Onkol 180: 805-810.
17. Gibson KM, Chan C, Chapuis PH, Dent OF, Bokey L (2014) Mural and extramural venous invasion and prognosis in colorectal cancer. Dis Colon Rectum 57: 916-926.
18. Glimelius B, Tiret E, Cervantes A, Arnold D. Group, EGW (2013) Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Suppl 6): vi81-vi88.
19. Hunter CJ, Garant A, Vuong T, Artho G, Lisbona R, Tekkis P, Abulafi M, Brown G (2012) Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment. Ann Surg Oncol 19: 1199-1205.
20. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, Mcquay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17: 1-12.
21. Jhaveri KS, Hosseini-Nik H, Thipphavong S, Assarzadegan N, Menezes RJ, Kennedy ED, Kirsch R (2016) MRI detection of extramural venous invasion in rectal cancer: correlation with histopathology using elastin stain. AJR Am J Roentgenol 206: 747-755.
22. Kim H, Myoung S, Koom WS, Kim NK, Kim MJ, Ahn JB, Hur H, Lim JS (2016) MRI risk stratification for tumor relapse in rectal cancer achieving pathological complete remission after neoadjuvant chemoradiation therapy and curative resection. PLoS One 11: e0146235.
23. Kirsch R, Messenger DE, Riddell RH, Pollett A, Cook M, Al-Haddad S, Streutker CJ, Divaris DX, Pandit R, Newell KJ, Liu J, Price RG, Smith S, Parfitt JR, Driman DK (2013) Venous invasion in colorectal cancer: impact of an elastin stain on detection and interobserver agreement among gastrointestinal and nongastrointestinal pathologists. Am J Surg Pathol 37: 200-210.
24. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339: b2700.
25. Mercury Study Group (2006) Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 333: 779.
26. Messenger DE, Driman DK, Kirsch R (2012) Developments in the assessment of venous invasion in colorectal cancer: implications for future practice and patient outcome. Hum Pathol 43: 965-973.
27. Messenger DE, Driman DK, Mcleod RS, Riddell RH, Kirsch R (2011) Current practice patterns among pathologists in the assessment of venous invasion in colorectal cancer. J Clin Pathol 64: 983-989.
28. Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial Protocol. Available at: https://clinicaltrials.gov/ct2/show/NCT01995942 Accessed on 17 August 2016.
29. National Institute of Clinical Excellence (2011) UK NICE guidelines. Available at: http://www.nice.org.uk/guidance/cg131/chapter/1-recommendations.
30. National Comprehensive Cancer Network (2015) NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer. V.3.2015. Available at: www.nccn.org/professionals/physician-gls/pdf/rectal.pdf Accessed on 27 January 2016.
31. NICE (2011) Colorectal Cancer: Diagnosis and Management. NICE Colorectal Cancer: Diagnosis and Management. Available at: https://www.nice.org.uk/guidance/cg131/resources/colorectal-cancer-diagnosis-and-management-35109505330117.
32. Nilsson PJ, Van Etten B, Hospers GA, Pahlman L, Van De Velde CJ, Beets-Tan RG, Blomqvist L, Beukema JC, Kapiteijn E, Marijnen CA, Nagtegaal ID, Wiggers T, Glimelius B (2013) Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer-the RAPIDO trial. BMC Cancer 13: 279.
33. Nougaret S, Reinhold C, Mikhael HW, Rouanet P, Bibeau F, Brown G (2013) The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the 'DISTANCE'? Radiology 268: 330-344.
34. Quasar Collaborative Group, Gray R, Barnwell J, Mcconkey C, Hills RK, Williams NS, Kerr DJ (2007) Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 370: 2020-2029.
35. Rangel SJ, Kelsey J, Colby CE, Anderson J, Moss RL (2003) Development of a quality assessment scale for retrospective clinical studies in pediatric surgery. J Pediatr Surg 38: 390-396, discussion 390-396.
36. Seehaus A, Vaccaro C, Quadrelli M, Calvo M, Rossi G, Savluk L, Pablo Santino J, Ojea Quintana G, Garćia Mónaco R (2015) Magnetic resonance and extramural vascular invasion in patients with rectal cancer and liver metastases. Acta Gastroenterol Latinoam 45: 31-36.
37. Shihab OC, Taylor F, Salerno G, Heald RJ, Quirke P, Moran BJ, Brown G (2011) MRI predictive factors for long-term outcomes of low rectal tumours. Ann Surg Oncol 18: 3278-3284.
38. Siddiqui M, Chand M, Bhoday J, Tekkis P, Abulafi AM, Brown G (2015) Correlation between MRI Detected Extra-Mural Vascular Invasion (mrEMVI) in Rectal Cancer and Metastatic Disease: a Meta-Analysis. PROSPERO 2015:CRD42015027923. Available at: http://www.crd.york.ac.uk/PROSPERO/display-record.asp?ID=CRD42015027923.
39. Slesser AA, Khan F, Chau I, Khan AZ, Mudan S, Tekkis PP, Brown G, Rao S (2015) The effect of a primary tumour resection on the progression of synchronous colorectal liver metastases: an exploratory study. Eur J Surg Oncol 41: 484-492.
40. Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi AM, Brown G (2008) Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 95: 229-236.
41. Sohn B, Lim JS, Kim H, Myoung S, Choi J, Kim NK, Kim MJ (2014) MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer. Eur Radiol 25: 1347-1355.
42. Stewart CJ, Morris M, De Boer B, Iacopetta B (2007) Identification of serosal invasion and extramural venous invasion on review of Dukes' stage B colonic carcinomas and correlation with survival. Histopathology 51: 372-378.
43. Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJ, Morson BC (1980) The clinical significance of invasion of veins by rectal cancer. Br J Surg 67: 439-442.
44. Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJ, Morson BC (1981) Spread of rectal cancer within veins. Histologic features and clinical significance. Am J Surg 141: 15-17.
45. Taylor FG, Quirke P, Heald RJ, Moran B, Blomqvist L, Swift I, Sebag-Montefiore DJ, Tekkis P, Brown G, Group, MS (2011) Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg 253: 711-719.
46. Taylor FG, Quirke P, Heald RJ, Moran BJ, Blomqvist L, Swift IR, Sebag-Montefiore D, Tekkis P, Brown G, Magnetic Resonance Imaging in Rectal Cancer European Equivalence Study, G (2014a) Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. J Clin Oncol 32: 34-43.
47. Taylor FGM, Quirke P, Heald RJ, Moran BJ, Blomqvist L, Swift IR, Sebag-Montefiore D, Tekkis P, Brown G (2014b) Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY Study. J Clin Oncol 32: 34-U114.
48. Taylor FGM, Swift RI, Blomqvist L, Brown G (2008) A systematic approach to the interpretation of preoperative staging MRI for rectal cancer. AJR Am J Roentgenol 191: 1827-1835.
49. Thomson E, Scott N, Tolan D (2015) Re: the prognostic significance of MRI-detected extramural venous invasion in rectal carcinoma. Clin Radiol 70: 111-112.
50. Ueno H, Mochizuki H, Hashiguchi Y, Ishiguro M, Miyoshi M, Kajiwara Y, Sato T, Shimazaki H, Hase K (2007) Extramural cancer deposits without nodal structure in colorectal cancer: optimal categorization for prognostic staging. Am J Clin Pathol 127: 287-294.
51. Ueno H, Mochizuki H, Shirouzu K, Kusumi T, Yamada K, Ikegami M, Kawachi H, Kameoka S, Ohkura Y, Masaki T, Kushima R, Takahashi K, Ajioka Y, Hase K, Ochiai A, Wada R, Iwaya K, Nakamura T, Sugihara K, Study Group for Tumor Deposits Without Lymph Node Structure in Colorectal Cancer Projected by The Japanese Society for Cancer of the ColonRectum (2012) Multicenter study for optimal categorization of extramural tumor deposits for colorectal cancer staging. Ann Surg 255: 739-746.
52. Yu SKT, Chand M, Tait DM, Brown GJ (2014) Magnetic resonance imaging defined mucinous rectal carcinoma is an independent imaging biomarker for poor prognosis and poor response to preoperative chemoradiotherapy. Eur J Cancer 50: 920-927.